BDBM257505 US9505736, (1R,2R,3R)-1-Fluoro-N-hydroxy-2-(4-(5- methylpyrimidin-2-yl)phenyl)-3- phenylcyclopropanecarboxamide
SMILES: Cc1cnc(nc1)-c1ccc(cc1)[C@H]1[C@H](c2ccccc2)[C@]1(F)C(=O)NO
InChI Key: InChIKey=LERFWXLGVNOQCJ-BBTUJRGHSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Histone deacetylase 4 (HDAC4) (Homo sapiens (Human)) | BDBM257505 (US9505736, (1R,2R,3R)-1-Fluoro-N-hydroxy-2-(4-(5- ...) | PDB GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.43E+3 | n/a | n/a | n/a | n/a | 8.0 | 25 |
CHDI Foundation, Inc. US Patent | Assay Description The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati... | US Patent US9505736 (2016) BindingDB Entry DOI: 10.7270/Q2T152KR | |||||||||||
More data for this Ligand-Target Pair |